| | | | 单位:元 币种:人民币 | | --- | --- | --- | --- | | 主要会计数据 | 本报告期 | 上年同期 | 本报告期比上 | | | (1-6月) | | 年同期增减(%) | | 营业收入 | 284. 036. 747.38 | 230.754.593.03 | 23. 09 | | 利润总额 | -8. 946. 556. 63 | -16.374.304.03 | 不适用 | | 归属于上市公司股东的净利润 | -7,061, 056. 54 | -8, 444, 249. 31 | 不适用 | | 归属于上市公司股东的扣除非经常性 损益的净利润 | -6, 759, 610. 05 | -7.983.544. 97 | 不适用 | | 经营活动产生的现金流量净额 | 100. 788. 676. 45 | 111.240.850.65 | -9. 40 | | | 本报告期末 | 上年度末 | 本报告期末比 上年度末增减 | | | | | (%) | | 归属于上市公司股东的净资产 | 1.126,888, 476.08 | 1, 106, 774, 363. ...

证券之星消息，2025年8月22日伟测科技（688372）发布公告称公司于2025年8月21日接受机构调研，鹏华基金、博时 基金、东兴基金、富国基金、中海基金、先锋基金、华宝基金、西部利得基金、天风证券、磐厚动量、嘉实基金、中 金资管、富安达基金、长信基金、UBS、中信保诚基金、长江证券、高毅资产、兴证全球基金、招商电子、中泰证 券、中邮证券、名禹资产、平安证券、长城证券、泰康基金、正圆私募、上银基金、华金证券、东海基金、光证资 管、全天候私募、汇丰前海证券、恒越基金、圆信永丰基金、国联民生、国信证券、上海亥鼎云天私募、创金合信基 金、广发证券、国泰基金、前海开源基金、利位投资、长安基金、易方达、中信证券、天朗私募、中信建投基金、华 夏久盈资产、南方基金、华夏基金、中金基金、砥俊资产、国融证券、百嘉基金、博普资产、途灵资产、圣为投资、 国海富兰克林基金、浦银安盛基金、禹田资产、五地私募、国信证券资产、中银基金、建信理财、东盈投资、笃诚私 募、瑞华投资、星石投资、泰信基金、华泰资产、南土资产、建信基金、浙商证券、华泰证券资产管理、中国人保健 康、淡水泉、东方红资产管理、方正证券、晨燕资产参与。 具体内容如下： ...

Core Viewpoint - The company, Weicet Technology, has experienced explosive growth in its performance in the first half of 2025, driven by increasing demand for advanced packaging testing services in the semiconductor industry [1][2]. Financial Performance - In the first half of 2025, Weicet Technology achieved revenue of 634 million yuan, a year-on-year increase of 47.53%, and a net profit of 101 million yuan, up 831.03% [1][2]. - The second quarter of 2025 saw revenue reach 349 million yuan, marking a historical high for the company, with a year-on-year growth of 41.68% and a net profit of 75 million yuan, which is over five times the previous year [2]. - The company's cash flow from operating activities for the first half of 2025 was 339 million yuan, a 67.70% increase from the same period last year [2]. Business Segments - Weicet Technology's core business includes wafer testing and finished chip testing, covering the entire lifecycle of chip testing services [2][4]. - In the first half of 2025, wafer testing revenue was 351 million yuan, accounting for 55.40% of total revenue, while finished chip testing revenue was 254 million yuan, making up 40.09% [2]. Market Performance - The company's stock price has been active in the secondary market, closing at 76.2 yuan per share on August 21, 2025, with a year-to-date increase of 70.28% and a total market capitalization of 11.35 billion yuan [3]. Research and Development - Weicet Technology has been increasing its investment in R&D, with a total investment of 466 million yuan from 2020 to the first half of 2025, representing 12.95% of total revenue in the first half of 2025 [5]. - The company has a total of 499 R&D personnel, accounting for 23.62% of the total workforce, which is an increase of 1.37 percentage points year-on-year [5].

Core Viewpoint - The credit rating report for Guangdong Liyang Chip Testing Co., Ltd. maintains a stable outlook, reflecting the company's capacity expansion and good cash flow performance, despite facing competitive pressures and potential risks related to debt and imported equipment reliance [4][7][9]. Company Overview - Guangdong Liyang Chip Testing Co., Ltd. is an independent third-party integrated circuit testing service provider, focusing on chip testing solution development, wafer testing services, and finished chip testing services [11]. - The company has established a good cooperative relationship with well-known clients in the integrated circuit design sector, including companies like Goodix Technology and Allwinner Technology [15][19]. Financial Performance - The company's total revenue for 2024 was 4.88 billion yuan, a decrease from 5.03 billion yuan in 2023, with a significant drop in gross profit margin from 30.33% to 20.90% [5][15]. - Operating cash flow showed a net inflow of 2.04 billion yuan in 2024, indicating improved cash flow performance compared to previous years [7][8]. - The company's total debt increased to 12.36 billion yuan in 2025, up from 7.21 billion yuan in 2023, reflecting rapid growth in debt levels [5][22]. Industry Environment - The integrated circuit testing industry is experiencing structural growth, with the global semiconductor market expected to reach $620.2 billion in 2024, a 17% increase year-on-year [12]. - The domestic independent testing market is still in its early stages, with significant potential for growth as high-end testing demands increase [13][14]. Competitive Landscape - The industry faces intense competition, with many players expanding their testing capabilities, which may pressure the company's market position [7][9]. - The company is expanding its testing capacity and diversifying its service offerings, including investments in wafer dicing and other related services [16][18]. Future Outlook - The company has a stable credit rating outlook, supported by its accumulated testing platforms and quality customer resources, indicating good business sustainability [9][10]. - However, the company must navigate challenges related to capacity utilization and potential financial leverage increases due to ongoing capital investments [22][23].

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company has announced a restricted stock incentive plan, granting 1.021 million shares, representing approximately 0.69% of the total share capital at the time of the announcement [4] - The company aims to achieve revenue targets of 1.4 billion, 1.7 billion, and 2 billion for the years 2025, 2026, and 2027, respectively, reflecting year-on-year growth rates of 30%, 21.4%, and 17.6% [7] - A new base will be established in Chengdu with an investment of 1 billion yuan, aimed at enhancing the national strategic layout and increasing market share [7] - The company is also increasing investments in its Wuxi and Nanjing bases, with a total capital expenditure of 1.483 billion yuan in 2024, focusing on high-end testing equipment [7] - The profit forecast has been adjusted, with expected net profits of 177 million, 249 million, and 362 million yuan for 2025, 2026, and 2027, respectively, corresponding to PE ratios of 50, 35, and 24 [7] Financial Data and Profit Forecast - Total revenue is projected to reach 1.401 billion yuan in 2025, with a year-on-year growth rate of 30.1% [6] - The net profit attributable to the parent company is expected to be 177 million yuan in 2025, reflecting a significant increase from the previous year [6] - The company's gross margin is forecasted to be 38.9% in 2025, with a gradual increase in ROE from 6.4% in 2025 to 10.7% in 2027 [6]

Group 1 - The issuer, Guangdong Leadyo IC Testing Co., Ltd., has been approved to issue 5.2 million convertible bonds with a total fundraising amount of RMB 520 million, with a maturity of 6 years [1][2] - The bonds have an interest rate of 2.0% in the fifth year and 2.5% in the sixth year, with interest paid annually [1][2] - The company is a well-known independent third-party professional testing service provider in China, focusing on integrated circuit testing solutions and services [2][3] Group 2 - In 2024, the company's operating income was RMB 48,812.56 million, a decrease of 2.97% compared to RMB 50,308.45 million in 2023 [3][5] - The net profit attributable to shareholders was -RMB 6,161.87 million, a significant decline of 383.69% from RMB 2,172.08 million in the previous year [3][5] - The total assets of the company increased by 25% to RMB 259,274.76 million by the end of 2024 [3][5] Group 3 - The company has a debt-to-asset ratio of 56.74% at the end of 2024, up from 45.26% in 2023, indicating a higher level of leverage [5] - The current ratio improved to 1.71 from 0.87, and the quick ratio increased to 1.65 from 0.82, suggesting better short-term liquidity [5] - The company has not implemented any credit enhancement measures for the convertible bonds [5] Group 4 - The company has established a special account for the raised funds, with a total of RMB 51,288.91 million raised and RMB 28,480.15 million utilized in 2024 [4] - The funds were primarily allocated to the "East City Leadyo Chip Integrated Circuit Testing Project" and for supplementing working capital [4] - The company has complied with its information disclosure obligations and has not encountered issues in this regard [4][5]

Group 1 - The company has approved the proposal for the provision of asset impairment reserves for the year 2024, which complies with accounting standards and reflects the financial status and operating results as of December 31, 2024 [21][22][23] - The board of directors has also approved the proposal to convene the 2024 annual general meeting of shareholders, with unanimous support from the board members [3][2] Group 2 - The supervisory board held its eighth meeting on April 29, 2025, where all members were present, and the meeting was conducted in accordance with legal and regulatory requirements [6] - The supervisory board approved the 2024 annual report and its summary, ensuring that the report accurately reflects the company's financial status and operating results [7][9] - The supervisory board also approved the 2024 work report, confirming that it has conducted due diligence on the company's operations and decisions [10][11] - The board approved the special report on the use of raised funds for 2024, confirming compliance with relevant regulations and proper usage of funds [12][13] - The internal control evaluation report for 2024 was approved, indicating that the company has established effective internal control systems [14][15] - The financial settlement report for 2024 was approved, reflecting the company's financial condition and operating results accurately [16][17] - The profit distribution plan for 2024 was approved, considering the company's profitability and cash flow [18][19] Group 3 - The company plans to apply for a comprehensive credit limit of up to RMB 2 billion (or equivalent foreign currency) for 2025, which will be used to support the business development of the company and its subsidiaries [24][28] - The company will provide guarantees for its wholly-owned subsidiaries, with the total guarantee amount also not exceeding RMB 2 billion [19][30] - The board of directors has recommended that the shareholders' meeting approve the comprehensive credit application and guarantee proposal [38][39] Group 4 - The company will hold an investor briefing on May 19, 2025, to discuss the 2024 annual results and the first quarter of 2025, allowing for interactive communication with investors [42][43] - Investors can submit questions in advance from May 12 to May 16, 2025, and participate in the online meeting [40][45]

Investment Rating - The report maintains a "Buy" rating for the company [4]. Core Insights - The company reported a revenue of 1.077 billion yuan for 2024, representing a year-over-year increase of 46.21%. The net profit attributable to shareholders was 128 million yuan, up 8.67% year-over-year [4]. - In Q1 2025, the company achieved a revenue of 285 million yuan, marking a 55.39% year-over-year growth, and a net profit of 26 million yuan, indicating a turnaround from losses [4]. - The company is increasing its investment in high-end production capacity and has completed significant capital expenditures, totaling 1.483 billion yuan in 2024, to enhance its competitive position in the market [6]. Financial Data and Profit Forecast - The company’s total revenue is projected to grow from 1.401 billion yuan in 2025 to 2.306 billion yuan by 2027, with year-over-year growth rates of 30.1%, 29.1%, and 27.6% respectively [5]. - The net profit attributable to shareholders is expected to rise from 187 million yuan in 2025 to 386 million yuan in 2027, with corresponding year-over-year growth rates of 46.0%, 43.0%, and 44.1% [5]. - The earnings per share are forecasted to increase from 1.64 yuan in 2025 to 3.39 yuan in 2027 [5]. Revenue and Profitability Analysis - The company’s revenue from CP testing reached 615 million yuan in 2024, a 38.91% increase year-over-year, while FT testing revenue was 367 million yuan, up 50.07% year-over-year [6]. - The gross margin for CP testing was 42.45%, and for FT testing, it was 29.16%, with slight decreases compared to the previous year [6]. - The company’s R&D investment increased by 37.16% year-over-year to 142 million yuan, reflecting a commitment to innovation and development [6].